Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer.

P C Hoffman1, A M Mauer, E E Vokes

  • 1Department of Medicine, University of Chicago, IL, USA.

Lancet (London, England)
|June 7, 2000
PubMed
Summary
This summary is machine-generated.

Lung cancer is a significant global health issue. Advances in diagnostics, surgical resection for early-stage non-small-cell lung cancer, and new chemotherapy regimens offer improved outcomes for various lung cancer types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

"Timing is Everything": the evolving role of immune checkpoint inhibition in nasopharyngeal carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Diagnostics

Background:

  • Lung cancer is a leading cause of cancer mortality worldwide.
  • Increasing incidence of lung adenocarcinoma presents evolving clinical challenges, including early metastasis.
  • Recent advancements in diagnostic techniques improve tumor staging and treatment strategies.

Purpose of the Study:

  • To provide an overview of the current landscape of lung cancer treatment.
  • To highlight progress in managing both non-small-cell lung cancer and small-cell lung cancer.
  • To discuss the impact of new diagnostic and therapeutic approaches.

Main Methods:

  • Review of current diagnostic techniques for lung cancer.
  • Analysis of treatment outcomes for early-stage, locally advanced, and metastatic non-small-cell lung cancer.

Related Experiment Videos

  • Evaluation of chemotherapy and radiation therapy advancements for small-cell lung cancer.

    • Main Results:

    • Surgical resection is effective for early-stage non-small-cell lung cancer.
    • Combined chemotherapy and radiation improve outcomes for locally advanced cancers.
    • Newer chemotherapy regimens show favorable results for metastatic disease.
    • Small-cell lung cancer demonstrates high responsiveness to chemotherapy, with improved survival from radiation therapy advances.

    Conclusions:

    • Innovative screening techniques and treatment approaches offer hope for significant progress in combating lung cancer.
    • Multimodal treatment strategies are crucial for improving patient survival and outcomes.
    • Ongoing research and technological advancements are vital for future breakthroughs in lung cancer care.